Purchase Order 36C26126P0245
- Not listed
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 for TAVR (transcatheter aortic valve replacement) products. The contract, which was not set aside for any business category, is scheduled for completion by November 17, 2025, with performance occurring in Minneapolis, Minnesota. As the sole manufacturer of the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, was awarded a firm fixed-price purchase order valued at $34,000 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 23 on September 23, 2025. The contract, which is not set-aside designated, covers transcatheter aortic valve replacement (TAVR) medical devices and is scheduled for completion by September 24, 2025. The award supports the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 23 for transcatheter aortic valve replacement (TAVR) medical devices. The contract was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, and will be performed in Minneapolis, Minnesota. This award represents a direct...
- Edwards Lifesciences LLC received a $68,000 firm fixed-price purchase order from Veterans Integrated Service Network 1 (VISN 1), a civilian component of the U.S. Department of Veterans Affairs, for the procurement of TAVR (transcatheter aortic valve replacement) heart valves. The contract, awarded on November 3, 2025, is scheduled for completion by February 3, 2026, with performance taking place in Irvine, California. This purchase order represents a non-set-aside award and carries no...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order contract by Veterans Integrated Service Network 20 on November 12, 2025, for prosthetics related to transcatheter aortic valve replacement (TAVR) technology. The contract, valued at $136,000 with an ultimate completion date of November 11, 2026, will be performed in Irvine, California. No set-aside designation was used...
- Edwards Lifesciences LLC has been awarded a $16,000 firm fixed-price purchase order by Veterans Integrated Service Network 22, a component of the U.S. Department of Veterans Affairs, for prosthetics emergency heart valve surgical implants. The contract, awarded December 9, 2025, with an ultimate completion date of January 31, 2026, will be performed in Irvine, California. This purchase order represents a tactical procurement to support immediate veteran healthcare needs for advanced...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 23 for a TAVR (transcatheter aortic valve replacement) kit prosthetics delivery on October 24, 2025. The contract, valued at $34,000, is not subject to any set-aside designation and is scheduled for completion by October 28, 2025. The award supports the Department of Veterans Affairs'...
- Edwards Lifesciences LLC, a leading manufacturer of advanced cardiovascular medical devices, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 4 (a civilian component of the Department of Veterans Affairs) on October 21, 2025, for transcatheter heart valves. The contract, valued at $34,000, carries no set-aside designation and is scheduled for completion by January 21, 2026. The products will be delivered to the place of performance in Irvine, California....
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $32,500 firm fixed-price purchase order to Edwards Lifesciences LLC on November 3, 2025, for transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics. The contract has no set-aside designation and is scheduled for completion by February 2, 2026, with performance taking place in San Francisco, California. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order on December 8, 2025, by Veterans Integrated Service Network (VISN) 23 for TAVR (transcatheter aortic valve replacement) equipment and related products. The contract, with a ceiling value of $34,000, has an ultimate completion date of December 10, 2025, and will be performed in Minneapolis, Minnesota. No set-aside...
Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation, has been awarded a firm fixed-price purchase order valued at $32,500 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 21 for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract, which carries no set-aside designation, is scheduled for completion by March 14, 2026, with the place of performance located in San Francisco, California. As the sole manufacturer of the specified heart valve products, Edwards Lifesciences LLC will supply highly specialized cardiovascular medical devices essential for surgical procedures supporting veteran healthcare across the VA system. This purchase order represents a component of Edwards Lifesciences LLC's broader contractual relationship with the Department of Veterans Affairs, which includes two significant Indefinite Delivery Contracts valued at $2.5 million and $1.25 million respectively. The company is positioned as a critical supplier of advanced cardiovascular technologies to the federal healthcare system, with Edwards Lifesciences LLC certified as a small disadvantaged business. This restock contract enables VISN 21 to maintain adequate inventory of short shelf-life cardiac devices for immediate availability during surgical interventions, supporting the VA's mission to deliver specialized cardiac care to veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.5k | 12/15/25 |